You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys CA 72-4 IVD Elecsys® CA 72-4 CPS_000450 09 005 692 190 9 005 692 190 09005692190 9005692190 09005692190 CA 72-4 Elecsys cobas e 100 V2 Elecsys CA 72-4 07613336171523 Reagents, kits 100 tests cobas e 411/601/602 true 09 005 706 190 9 005 706 190 09005706190 9005706190 09005706190 CA 72-4 Elecsys E2G 300 V2 Elecsys CA 72-4 07613336171530 Reagents, kits 300 tests cobas e 402/801 true 09 744 525 190 9 744 525 190 09744525190 9744525190 09744525190 CA 72-4 Elecsys E2G 100 V2 Elecsys CA 72-4 07613336217610 Reagents, kits 100 tests cobas e 402/801 true 09005692500 Elecsys CA 72-4 en 2 FF00000004B4DB0E FF0000000493AF0E 09005692190 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use
Immunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09005706500 Elecsys CA 72-4 en 2 FF00000006730A0E FF000000045ACA0E 09005706190 09005706214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09744525500 Elecsys CA 72-4 en 1 FF000000066E3A0E FF000000066E3A0E 09744525190 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of CA 72‑4 in human serum and plasma. The assay in particular serves as an aid in the therapeutic monitoring of carcinomas of the stomach and ovaries.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en